Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
RV Invest is a venture capital fund based in Germany, specializing in future medicines. The firm was founded to support innovations that improve patients' lives, engaging early with founders and researchers. They focus on bringing technical solutions to market that could become future standards of care.
RV Invest targets the biotechnology and pharmaceutical sectors, investing in early-stage companies developing differentiated technical solutions in healthcare. They participate in pre-seed, seed, seed+, and Series A rounds, aiming to support innovations that can significantly impact patient care.
Notable portfolio companies include Akribion Therapeutics, which is developing RNA-guided, nuclease-based technology for programmable cell depletion; Alesta Therapeutics, pioneering small molecule therapies for rare diseases; Arda Therapeutics, focused on targeted cell depletion for chronic diseases; Asgard Therapeutics, working on direct in vivo cell reprogramming for cancer immunotherapy; and Diagonal Therapeutics, developing new disease-modifying therapies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.